Friday, May 12, 2023 12:30 PM – 2:30 PM ET Room 201
Block Symposium
Cytokines and Vaccines for the Treatment of Cancer
Chairs
- Jenny Jiang, Univ. of Pennsylvania
- Michelle Krogsgaard, New York Univ. Sch. of Med.
Speakers
- Kyle J. Kaeo, Johns Hopkins Univ., Engineering antibody fusion proteins for targeted intracellular therapeutic delivery
- Max Mu Wang, Northwestern Univ., Design and optimization of a novel proteomimetic polymer nanoplatform for the co-delivery of antigens with adjuvants
- Haiyan Liu, Natl. Univ. of Singapore, RNA-based personalized cancer vaccine for AML immunotherapy
- Aliyah Brianne Silver, Johns Hopkins Bloomberg Sch. of Public Hlth., Design and characterization of a tumor-retained interleukin-2 cytokine/antibody fusion protein for cancer immunotherapy
- Yuanzhi Bian, Virginia Tech, Cytometric analysis authenticates adjuvanticity of interferon-γ and suggests potential synergy with toll-like receptor agonists
- Kou Hioki, Erasmus Univ. Med. Ctr., Netherlands, A combination of TLR9 and STING agonists induces potent neopeptide-specific T cell immunity and improves ICB efficacy in tumor models
- Jianmei Wu Leavenworth, Univ. of Alabama at Birmingham, Reshaping the anti-tumor CD4 T-cell repertoire contributes to oncolytic virus therapeutic efficacy in malignant glioma
- Rachel P. Wallace, Univ. of Chicago, Synthetically mannosylated antigens impair the antigen-specific humoral immune response and prolong the therapeutic efficacy of immunogenic protein drugs
